期刊文献+

先天性类脂质性肾上腺增生症的研究进展 被引量:1

Research progress of congenital lipoid adrenal hyperplasia.
下载PDF
导出
摘要 先天性类脂质性肾上腺增生症(CLAH)是先天性肾上腺增生症(CAH)中最为严重的一种类型,主要是由类固醇生成急性调控蛋白(StAR)基因和编码胆固醇侧链裂解酶(P450scc)基因突变引起,是一种常染色体隐形遗传疾病。典型的CLAH多在患儿出生不久后即出现失盐及肾上腺功能不全的症状,如脱水、低钠血症、高钾血症等,同时合并有性发育障碍、皮肤色素沉着,治疗上多以对症治疗及皮质激素治疗为主,若不及时治疗,有可能出现肾上腺危象,危及患者生命。目前CLAH具体发病机制不详,本文主要就CLAH、StAR、P450scc及三者之间的联系予以(综述),以期为CLAH的研究进展提供参考依据。 Congenital lipoid adrenal hyperplasia(CLAH)is the most serious type of congenital adrenal hyper-plasia(CAH).It is mainly caused by mutation of steroid acute regulatory protein(StAR)gene and gene encoding choles-terol side chain lyase(P450scc),and it is an autosomal recessive genetic disease.Typical CLAH often appears symptoms such as dehydration,hyponatremia,hyperkalemia shortly after the birth of children.At the same time,it is complicated with sexual development disorder and skin pigmentation.Symptomatic treatment and corticosteroid treatment are the main treatment methods.If not treated in time,adrenal crisis may occur,endangering patients'lives.At present,the spe-cific pathogenesis of CLAH is unknown.This article mainly reviews CLAH,StAR,P450scc,and their relationship,in or-der to provide reference for the research progress of CLAH.
作者 荣柳萍(综述) 宋文秀(审校) RONG Liu-ping;SONG Wen-xiu(Department of Pediatrics,the Fifth Affiliated Hospital(Zhuhai)of Zunyi Medical College,Zhuhai 519100,Guangdong,CHINA)
出处 《海南医学》 CAS 2022年第16期2153-2157,共5页 Hainan Medical Journal
关键词 先天性类脂质性肾上腺增生症 类固醇生成急性调控蛋白 编码胆固醇侧链裂解酶 肾上腺功能不全 类固醇激素 Congenital lipoid adrenal hyperplasia Steroids produce acute regulatory proteins Encoding choles-terol side chain lyase Adrenal insufficiency Steroid hormone
  • 相关文献

参考文献9

二级参考文献40

  • 1张波,陆召麟,王玥,陶红.中国人21-羟化酶缺乏症基因型和临床表型特点研究[J].Acta Genetica Sinica,2004,31(9):950-955. 被引量:17
  • 2邱文娟,叶军,韩蓓,韩连书,顾学范.先天性类脂质性肾上腺增生症分子遗传学分析[J].中华儿科杂志,2004,42(8):585-588. 被引量:15
  • 3Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsycho-pharmacological properties[J]. Psychoneuroendocrinology, 2003, 28(2): 139-168.
  • 4Kim HJ, Ha M, Park CH, et al. StAR and steroidogenic enzyme transcriptional regulation in the rat brain: effects of acute alcohol administration[J]. Mol Brain Res, 2003, 115(1): 39-49.
  • 5Ukena K, Usui M, Kohchi C, et al. Cytochrome P450 side-chain cleavage in cerebellar purkinje neuron and its neonatal change in rats[J]. Endocrinology, 1998, 139(1): 137-147.
  • 6Mensah-Nyagan AG, Do-Rego JL, Beaujean D, et al. Neurosteroids: expression of steroidogenic enzymes and regulateon of steroid biosynthesis in the central nervous system[J]. Pharmacol Rev, 1999, 51(1): 63-81.
  • 7Le Goascogne G, Robel P, Gouezou M, et al. Neurosteroids: cytochrome P- 450scc in rat brain[J]. Science, 1987, 237(4819): 1212-1214.
  • 8Mellon SH, Griffin LD, Compagnone NA. Biosynthesis and action of neurosteroids[J]. Brain Res Rev, 2001, 37(1-3): 3-12.
  • 9Rupprecht R, Di-Michele F, Hermann B, et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropyschopharmacology[J]. Brain Res Rev, 2001, 37(1-3): 59-67.
  • 10宁光.提高非经典型21-羟化酶缺陷症的诊治水平[J].中华内分泌代谢杂志,2007,23(5):385-387. 被引量:4

共引文献28

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部